ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert C. Robbins
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poston, R. S.
Right arrow Articles by Robbins, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poston, R. S., Jr
Right arrow Articles by Robbins, R. C.

Ann Thorac Surg 1997;64:1004-1012
© 1997 The Society of Thoracic Surgeons

Original Article: Cardiovascular

Effects of Increased ICAM-1 on Reperfusion Injury and Chronic Graft Vascular Disease

Robert S. Poston, Jr, MD, Margaret E. Billingham, MD, Jeffrey Pollard, BS, E. Grant Hoyt, Robert C. Robbins, MD

Departments of Cardiothoracic Surgery and Pathology, Stanford University School of Medicine, Stanford, California

Background. The purpose of this study was to assess the impact of increased donor cardiac intercellular adhesion molecule (ICAM-1) expression on both reperfusion injury and chronic graft vascular disease after transplantation.

Methods. Hearts were harvested from donor rats before and after pretreatment with lipopolysaccharide at -24 hours, underwent 45 minutes of cold ischemia, and were transplanted into ACI recipients with or without anti–ICAM-1 monoclonal antibody treatment. Grafts were procured early for analysis of ICAM-1 expression and reperfusion injury or the recipients were treated with cyclosporin A (to allow long-term graft acceptance) for postoperative days 0 through 9 with procurement on postoperative day 90 to histologically score for chronic graft vascular disease.

Results. Lipopolysaccharide-pretreated PVG heart grafts showed increased ICAM-1 expression by Northern blot and immunohistochemical analysis leading to increased reperfusion injury as assessed by neutrophil infiltration (myeloperoxidase), cardiac edema (percentage wet weight), and histologic injury (percentage area of contraction band necrosis), which was reversed by recipient treatment with anti–ICAM-1 monoclonal antibody. After administration of cyclosporin A, 5 mg/kg for 10 days, lipopolysaccharide-treated grafts had significantly worse chronic graft vascular disease scores (2.56 ± 0.57 versus 1.84 ± 0.75; p < 0.05 by Mann-Whitney U test).

Conclusions. The induction donor inflammatory state before harvest leading to increased cardiac ICAM-1 expression promotes reperfusion injury and chronic graft vascular disease after transplantation in this rodent heterotopic heart model.




This article has been cited by other articles:


Home page
 Card Surg AdultHome page
B. P. Griffith, M. Haddad, and R. S. Poston
Immunobiology of Heart and Heart-Lung Transplantation
Card. Surg. Adult, January 1, 2008; 3(2008): 1513 - 1538.
[Full Text]

Home page
 CirculationHome page
M. Tanaka, K. Sydow, F. Gunawan, J. Jacobi, P. S. Tsao, R. C. Robbins, and J. P. Cooke
Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease
Circulation, September 13, 2005; 112(11): 1549 - 1556.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Tanaka, S. Nakae, R. D. Terry, G. K. Mokhtari, F. Gunawan, L. B. Balsam, H. Kaneda, T. Kofidis, P. S. Tsao, and R. C. Robbins
Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease
Blood, December 1, 2004; 104(12): 3789 - 3796.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Tanaka, R. D. Terry, G. K. Mokhtari, K. Inagaki, T. Koyanagi, T. Kofidis, D. Mochly-Rosen, and R. C. Robbins
Suppression of Graft Coronary Artery Disease by a Brief Treatment With a Selective {epsilon}PKC Activator and a {delta}PKC Inhibitor in Murine Cardiac Allografts
Circulation, September 14, 2004; 110(11_suppl_1): II-194 - II-199.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Tanaka, G. K. Mokhtari, R. D. Terry, L. B. Balsam, K.-H. Lee, T. Kofidis, P. S. Tsao, and R. C. Robbins
Overexpression of Human Copper/Zinc Superoxide Dismutase (SOD1) Suppresses Ischemia-Reperfusion Injury and Subsequent Development of Graft Coronary Artery Disease in Murine Cardiac Grafts
Circulation, September 14, 2004; 110(11_suppl_1): II-200 - II-206.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
B. P. Griffith and R. S. Poston
Immunobiology of Heart and Heart-Lung Transplantation
Card. Surg. Adult, January 1, 2003; 2(2003): 1403 - 1426.
[Full Text]

Home page
 J Am Coll CardiolHome page
M. H. Yamani, C. S. Masri, N. B. Ratliff, M. Bond, R. C. Starling, E. M. Tuzcu, P. M. McCarthy, and J. B. Young
The role of vitronectin receptor ({alpha}v{beta}3) and tissue factor in the pathogenesis of transplant coronary vasculopathy
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 804 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. C. Stoica, M. Goddard, and S. R. Large
The endothelium in clinical cardiac transplantation
Ann. Thorac. Surg., March 1, 2002; 73(3): 1002 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
K. M. Vural and M. C. Oz
Endothelial adhesivity, pulmonary hemodynamics and nitric oxide synthesis in ischemia-reperfusion
Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 348 - 352.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. Toda, K. Kayano, A. Karimova, Y. Naka, T. Fujita, K. Minamoto, C. Y. Wang, and D. J. Pinsky
Antisense Intercellular Adhesion Molecule-1 (ICAM-1) Oligodeoxyribonucleotide Delivered During Organ Preservation Inhibits Posttransplant ICAM-1 Expression and Reduces Primary Lung Isograft Failure
Circ. Res., February 4, 2000; 86(2): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. M. Vural, H. Liao, M. C. Oz, and D. J. Pinsky
Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model
Ann. Thorac. Surg., January 1, 2000; 69(1): 228 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
K. M. Vural, M. C. Oz, H. Liao, H. F. Batirel, and D. J. Pinsky
Membrane stabilization in harvested vein graft storage: effects on adhesion molecule expression and nitric oxide synthesis
Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 150 - 155.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Mann, G. H. Gibbons, H. Hutchinson, R. S. Poston, E. G. Hoyt, R. C. Robbins, and V. J. Dzau
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues
PNAS, May 25, 1999; 96(11): 6411 - 6416.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. S. Poston, M. Ennen, J. Pollard, E. G. Hoyt, M. E. Billingham, and R. C. Robbins
Ex vivo gene therapy prevents chronic graft vascular disease incardiac allografts
J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 386 - 390.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.